The results for adult IBD care—UC across the 2006, 2008 and 2010 rounds of the UK IBD audit, whenever directly comparable
| 2006 (1953 comparable cases of which 1668 non-elective) | 2008 (2016 comparable cases of which 1655 non-elective) | 2010 (1948 comparable cases of which 1614 non-elective) | |
|---|---|---|---|
| Mortality during the admission | 34/1953 (1.7%) | 31/2016 (1.5%) | 16/1948 (0.8%)* |
| Previous UC related admission in the 2 years before the audit | 829/1621 (51.1%) | 750/1655 (45.3%) | 421/1255 (33.6%)* |
| Inpatients’ review by an IBD nurse during their admission | 395/1667 (23.7%) | 496/1653 (30.0%) | 725/1614 (44.9%)* |
| Sending stool sample for SSC and CDT in non-elective patients with diarrhoea (recorded in the first full day following admission) | SSC 738/1120 (65.9%) | SSC 857/1160 (73.9%) | SSC 961/1189 (80.8%)* |
| CDT 604/1120 (53.9%) | CDT 770/1160 (66.4%) | CDT 882/1173 (75.2%)* | |
| Were the stool samples positive? | Not asked | SSC 17/857 (2.0%) CDT 32/770 (4.2%) | SSC 24/961 (2.5%) CDT 14/882 (1.6%)* |
| Prophylactic heparin prescription for non-elective admissions | 905/1668 (54.3%) | 1220/1649 (74%) | 1406/1614 (87.1%)* |
| Non-elective patients prescribed, but not responding to, corticosteroids during the admission who received either Ciclosporin or anti-TNF therapy | Ciclosporin 108/412 (26.2%) | Ciclosporin 117/433 (27.0%) | Ciclosporin 152/655 (23.2%) |
| Anti-TNF 20/412 (4.9%) | Anti-TNF 52/433 (12.0%) | Anti-TNF 110/655 (16.8%)* | |
| Laproscopic or laproscopically assisted surgery for non-responding elective patients | 28/274 (10.2%) | 58/362 (16.0%) | 145/332 (43.7%)* |
| Laproscopic or laproscopically assisted surgery for non-responding non-elective patients | 11/213 (5.2%) | 27/207 (13.0%) | 66/195 (33.9%)* |
| Bone protection agents prescription for UC patients on steroids | 534/1300 (41.1%) | 749/1347 (55.6%) | 971/1396 (69.6%)* |
Any statistically significant change is represented by an asterix to the right of the 2010 data column.
CDT, C difficile toxin; IBD, inflammatory bowel disease; SSC, standard stool culture; TNF, tumour necrosis factor; UC, ulcerative colitis.